Albany Molecular Research Announces Drug Discovery Research Collaboration with Alcon
10-Jan-2005
Most read news
Topics
Organizations
Albany Molecular Research
Alcon Research
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
Medical Park Hannover GmbH - Hannover, Germany
Go to page
Menlo Systems GmbH - Martinsried, Germany
Go to page
QIAGEN Completes Management Buyout of its Synthetic DNA Business Unit - Operon Biotechnologies Inc. - QIAGEN to Keep its siRNA Business and to Retain Preferred Access to Synthetic DNA Supply
Go to page
Number of cardiovascular risk factors could determine safety of intravenous gammaglobulin treatment
Go to page
Dyax Announces Second Peptide Discovery Collaboration with EPIX Pharmaceuticals
Go to page
New Diagnostic Device has the Potential to Save at least 375.000 Lives per Year - Health Care Systems worldwide would save up to $ 20 billion dollars with sepsis diagnosis alone.
Go to page
C-tec Cleanroom Technology GmbH - Rottenburg am Neckar, Germany
Go to page
XOMA Expands BCE Technology License with Crucell
Go to page
Causus_lichtensteinii
Go to page
Analytical Flow Products Inc - Quebec, Canada
Go to page
Genencor Launches Industry Transforming Technology for Ethanol Production - New enzyme technology removes the need for energy-intensive, costly cook step
Go to page
Nabriva reports successful Phase I clinical trial for BC-3781 - Studies presented at ECCMID alongside other papers relating to Nabriva’s pleuromutilin pipeline
Go to page